Rivaroxaban (Xarelto™) approved in Japan for patients with peripheral artery disease (PAD) after revascularisation
Berlin, June 21, 2022 - The Ministry of Health, Labor and Welfare in Japan has approved the use of the ...
Read moreBerlin, June 21, 2022 - The Ministry of Health, Labor and Welfare in Japan has approved the use of the ...
Read more© 2023 earth-news.info
..................................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....